{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,27]],"date-time":"2024-02-27T19:10:09Z","timestamp":1709061009120},"reference-count":6,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2009,1,1]],"date-time":"2009-01-01T00:00:00Z","timestamp":1230768000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Journal of Internal Medicine"],"published-print":{"date-parts":[[2009,1]]},"DOI":"10.1016\/j.ejim.2008.04.024","type":"journal-article","created":{"date-parts":[[2008,6,21]],"date-time":"2008-06-21T08:23:26Z","timestamp":1214036606000},"page":"e7-e8","source":"Crossref","is-referenced-by-count":1,"title":["Avoiding errors with intravenous erythromycin administration"],"prefix":"10.1016","volume":"20","author":[{"given":"F.","family":"Donnellan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Hussain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"McGurk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.ejim.2008.04.024_bib1","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1002\/j.1875-9114.1995.tb02883.x","article-title":"QT interval prolongation and torsades de pointes due to erythromycin lactobionate","volume":"15","author":"Oberg","year":"1995","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.ejim.2008.04.024_bib2","unstructured":"Intravenous Erythrocin lactobionate data sheet. www.fda.gov\/medwatch\/safety\/2004\/sep_PI\/Erytholactobionate_PIpdf.pdf"},{"issue":"8","key":"10.1016\/j.ejim.2008.04.024_bib3","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1007\/BF01708583","article-title":"Possible risk for cardiac arrhythmia related to intravenous erythromycin","volume":"18","author":"Haefeli","year":"1992","journal-title":"Intensive Care Med"},{"issue":"4","key":"10.1016\/j.ejim.2008.04.024_bib4","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/S0002-9343(98)00059-X","article-title":"QT prolongation and Torsades de Pointes associated with clarithromycin","volume":"104","author":"Lee","year":"1998","journal-title":"Am J Med"},{"issue":"7237","key":"10.1016\/j.ejim.2008.04.024_bib5","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1136\/bmj.320.7237.768","article-title":"Human error: models and management","volume":"320","author":"Reason","year":"2000","journal-title":"BMJ"},{"issue":"2","key":"10.1016\/j.ejim.2008.04.024_bib6","first-page":"146","article-title":"Medication errors: inadvertent administration of potassium chloride","volume":"11","author":"Emmett","year":"2003","journal-title":"J Law Med"}],"container-title":["European Journal of Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620508001386?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620508001386?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,2,27]],"date-time":"2024-02-27T18:31:14Z","timestamp":1709058674000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0953620508001386"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,1]]},"references-count":6,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009,1]]}},"alternative-id":["S0953620508001386"],"URL":"https:\/\/doi.org\/10.1016\/j.ejim.2008.04.024","relation":{},"ISSN":["0953-6205"],"issn-type":[{"value":"0953-6205","type":"print"}],"subject":[],"published":{"date-parts":[[2009,1]]}}}